The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a non-profit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.
The Technical Advisory Boards (ABs) of the PDA provide scientific and technical expertise to the PDA Board of Directors as well as day-to-day content management of scientific and technical initiatives intended for PDA publication. The ABs collaborate on matters of overlapping expertise and relevance, including best practices and new concept development, implementation, and communication. As appropriate, each develops and makes recommendations to the PDA Board of Directors on proposed PDA positions, which may include comments to regulators.
The Regulatory Affairs and Quality Advisory Board (RAQAB) of the PDA is composed of a diverse group of experts who provide guidance and set strategic direction on regulatory and quality topics spanning the lifecycle of healthcare products. These may include:
SeerPharma is delighted to announce that Senior Consultant Lisa Bennett has been accepted to join the RAQAB of the PDA. A three-year commitment, as a member of the Board, Lisa will be tasked to assist in the review of all relevant PDA technical publications, standards and regulatory guidelines as they are drafted and other activities such as participation in commenting teams, task force(s), interest group liaison, supporting PDA publications and/or PDA conference obligations.
Lisa’s insights in this position will help provide the wider team at SeerPharma with further insights and guidance on the challenges and trends in our sector. By doing so, helping us, help our clients even further on matters related to Quality and GMP compliance.